ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 9 March 2007. doi:10.1136/adc.2006.106617
Archives of Disease in Childhood 2008;93:200-203
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
adc.2006.106617v1
93/3/200    most recent
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Taylor, R E B
Right arrow Articles by Clark, J E
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R E B
Right arrow Articles by Clark, J E
Related Collections
Right arrowRelated Articles

Original articles

Potential effect of NICE tuberculosis guidelines on paediatric tuberculosis screening

R E B Taylor1, A J Cant2, J E Clark2

1 Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH
2 Newcastle General Hospital, Westgate Rd, Newcastle upon Tyne, NE4 6BE

Correspondence to:
Dr Julia Clark, Consultant in Paediatric Infectious Diseases, Department of Paediatric Infectious Disease, Newcastle General Hospital, Westgate Road, Newcastle, NE4 6BE; Julia.clark{at}nuth.nhs.uk

Objective: Assays based on interferon {gamma} (IFN{gamma}) are an exciting new development for screening for latent tuberculosis infection (LTBI) in adults, but there are limited data on their effectiveness in children. Nevertheless new National Institute for Health and Clinical Excellence (NICE) guidelines recommend their use when screening paediatric tuberculosis (TB) contacts. We evaluated the potential effect of the new NICE guidelines on current paediatric practice.

Design: Children screened for TB who had had an IFN{gamma} assay performed (QuantiFERON-TB Gold (QFG)) were included. Actual outcomes from existing guidelines were compared with those that would have been obtained using NICE guidelines.

Results: QFG assays were performed on 120 children, 103 as part of TB contact tracing. Six of the 120 (5%) were QFG positive, and seven of the 120 (6%) were indeterminate. Where both Mantoux and QFG results were available, these agreed in 62/104 (60%) of cases. QFG tests were more likely to correlate with a negative Mantoux (98% agreement) than with a positive Mantoux (11% agreement). Management outcomes differed for 23/103 children seen as part of TB contact tracing. Only one (1%) of these had an indeterminate QFG result. 17 (85%) fewer children would have been given LTBI treatment (chemoprophylaxis) and two (2%) children with possible TB would not have been identified using NICE guidelines.

Conclusion: New NICE guidelines for the use of IFN{gamma}-based tests for TB screening will reduce the number of children treated for presumed LTBI. Long-term prospective studies are needed to determine the number of children with positive Mantoux tests but negative IFN{gamma} results who are not given LTBI treatment yet later develop TB.



Related Articles

Atoms
Howard Bauchner, Editor-in-
Arch. Dis. Child. 2008 93: 1. [Extract] [Full Text] [PDF]

The tuberculin skin test: a hundred, not out?
Delane Shingadia and Vas Novelli
Arch. Dis. Child. 2008 93: 189-190. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
D. Shingadia and V. Novelli
The tuberculin skin test: a hundred, not out?
Arch. Dis. Child., March 1, 2008; 93(3): 189 - 190.
[Full Text] [PDF]

eLetters:

Read all eLetters

Let's not jump the gun!
Beate Kampmann
ADC Online, 10 Mar 2008 [Full text]
IGRA for children in the UK: patchy availability, problems with funding, unclarity about role.
Onajite M Etuwewe, et al.
ADC Online, 25 Mar 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health